Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724455 | SCV000229766 | uncertain significance | not provided | 2014-12-18 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000177826 | SCV000613970 | uncertain significance | not specified | 2016-08-22 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764628 | SCV000895736 | uncertain significance | Merosin deficient congenital muscular dystrophy; Muscular dystrophy, limb-girdle, autosomal recessive 23 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001248058 | SCV001421522 | likely benign | LAMA2-related muscular dystrophy | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000724455 | SCV003808213 | uncertain significance | not provided | 2021-04-05 | criteria provided, single submitter | clinical testing | |
Genome |
RCV001248058 | SCV001423457 | not provided | LAMA2-related muscular dystrophy | no assertion provided | phenotyping only | Variant interpretted as Uncertain significance and reported on 02-08-2015 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |